My Untitled Site

It's one of the hardest questions to answer on your own — you're deep in the product, and it's easy to lose perspective on the commercial side. A Commercial Readiness Assessment gives you an outside, structured view across the areas that matter most: product readiness, market opportunity, regulatory pathway, pricing, and more. You'll walk away with a clear picture of what's working and what needs attention, mapped into a 90-day action plan. The best way to find out where you actually stand? Book a free Discovery Call and we'll figure it out together.

If go-to-market questions — who's buying, how you'll price it, which channels make sense — feel harder to answer than the technical ones, that's usually the sign. So is watching momentum stall after a strong technical milestone, or realizing no one on your team has actually launched a product before. None of that means something's wrong with your company — it means the next problem to solve is a commercial one, not a technical one. A free Discovery Call is the fastest way to find out what's really going on.

Not necessarily — and for most early-stage companies, hiring full-time too early creates its own problem: a large fixed cost before you've validated what the role even needs to look like. Fractional commercial leadership gives you the same senior experience — go-to-market strategy, sales, revenue leadership — on a part-time or defined scope, so you get the leadership without the commitment. Many companies use this as the bridge until they're ready to hire permanently. Let's talk through what stage you're at and what actually makes sense.

An advisor is there when you need them — a second opinion on a plan, a gut check before a big decision, on your schedule. Fractional leadership is different: it's ongoing and embedded, actively driving the strategy and execution rather than just reacting to it. Neither is automatically the right answer — it depends on whether you need a sounding board or someone actually running point. A Discovery Call is the easiest way to figure out which one fits where you are right now.

No — and this is one of the most common things founders get wrong about timing. Some of the most valuable commercial work happens before clearance and before revenue, because the decisions you make early — positioning, regulatory-to-market timing, channel strategy — shape everything that comes after. Waiting until you're closer to launch often just means fixing avoidable mistakes instead of preventing them. If you're not sure whether now is too early, that's exactly what a free Discovery Call is for.

Cost shouldn't be the reason you stay stuck without a clear commercial plan. That's why every engagement starts with a free Discovery Call — no cost, no pressure — so we can understand exactly where you are and recommend the right level of support for your budget and stage. From there, pricing depends on scope: advisory support, a defined project, a full readiness assessment, or ongoing fractional leadership. Let's talk about what makes sense for you.

Because you don't need another framework — you need someone who's actually done this before. Signal Medtech is operator-led, built on hands-on commercial operating experience rather than advisory theory, and network-supported, so deeper specialist expertise — regulatory, market access, clinical evidence — gets brought in only when your specific situation calls for it, instead of being padded into every retainer. You get exactly the help you need, from someone who's been in the seat.

Most founders find out they're not fully ready in the middle of a raise, when it's the most expensive time to discover it. The Investor Readiness Assessment benchmarks your company against what investors actually evaluate — before you're in the room with them — so you can walk in with a defensible, third-party view of where you stand and what to tighten up first. It's available on its own or alongside any other engagement. Ready to see where you stand? Let's start with a free Discovery Call.

It's a question worth answering before it gets asked by an investor or a competitor, not after. The Intellectual Property Assessment screens your technology for novelty and competitive exposure — a similarity ranking against existing patents, a feature comparison against competing approaches, and a plain-language read on where you stand. It's a decision-support tool, not a substitute for legal counsel, but it gives you clarity fast. Happy to talk through whether it's the right next step for you.

It's a focused, no-cost conversation — not a sales pitch. We'll talk through where your company stands today, identify the gap that's costing you the most time or momentum, and figure out together whether Signal Medtech is actually the right fit. If it's not, that gets said directly. If it is, you'll leave the call knowing exactly what the right next step looks like. Getting started is simple: book your free Discovery Call whenever you're ready.